Skip to main content
. Author manuscript; available in PMC: 2024 Mar 27.
Published in final edited form as: Curr Treat Options Gastroenterol. 2020 Jan 21;18(1):109–119. doi: 10.1007/s11938-020-00271-5

Table 1.

Multi-target stool DNA demonstrates higher specificity in younger patients with normal colonoscopy

Patient Population Specificity
Imperiale et al [39]
 No CRC or advanced adenoma*, all ages 86.6%
 Negative colonoscopy, all ages 90%
 No CRC or advanced adenoma*, age 50-64 91.5%
 Negative colonoscopy, age 50-64 94%
Redwood et al [40]
 No CRC or advanced adenoma*, all ages 91%
 Negative colonoscopy, all ages 93%
*

Patients with non-advanced lesions, hyperplastic polyps and other findings (e.g. diverticulitis) included in specificity calculation